Skip to main content
. 2020 Apr 24;99(17):e19833. doi: 10.1097/MD.0000000000019833

Table 2.

Odds ratio and 95% confidence interval of association between hepatocellular carcinoma and cumulative duration of thiazolidinediones use among high risk subjects.

3.2.